Overview

A Study of VCT220 in Participants With Hypertension and Obesity or Overweight

Status:
NOT_YET_RECRUITING
Trial end date:
2026-12-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the safety and efficacy of VCT220 for the treatment of hypertension in participants with obesity or overweight.
Phase:
PHASE2
Details
Lead Sponsor:
Vincentage Pharma Co., Ltd